Status:
COMPLETED
An Ischaemic Stroke Observational Study
Lead Sponsor:
ReNeuron Limited
Conditions:
Stroke
Eligibility:
All Genders
Brief Summary
A non-interventional observational clinical study to document the clinical course of patients at 12 months or more following an ischaemic stroke
Detailed Description
Primary objective: To document and better define the prognostic characteristics of residual disability 12 months or more following an ischaemic stroke in patients that originally participated in the ...
Eligibility Criteria
Inclusion
- Capacity to give informed consent or witnessed informed consent in the event that the patient is unable to sign informed consent due to physical impairments.
- Participation in the preceding study RN-CS-0001
- Completion of at least one of the 4 functional assessment tests (ARAT, BI, NIHSS, mRS) at any time point on the previous study RN-CS-0001
- Ability to participate in all assessments and attend all visits
Exclusion
- Any additional incidence of stroke (Ischaemic or Haemorrhagic) since participation in the previous study RN-CS-0001 (since the last CS-0001 assessment visit date).
- Incidence of significant other disease that judged by the investigator would confound completion of all functional assessments (not excluding patients that can complete at least one functional assessment with no confounding factor from significant other disease).
Key Trial Info
Start Date :
May 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 6 2017
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03333980
Start Date
May 1 2017
End Date
November 6 2017
Last Update
December 5 2017
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
New Queen Elizabeth Hospital
Birmingham, United Kingdom
2
Ninewells Hospital & Medical School
Dundee, United Kingdom
3
Queen Elizabeth University Hospital.
Glasgow, United Kingdom
4
University College London Hospital Stroke Research Centre
London, United Kingdom